ELISA (host cell proteins)

The scope of the method is the quantitative determination of process related CHO host cell proteins in test samples in the range of 3 - 100 ng CHO HCP/ml

Therapeutic Modalities:

Biologics

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)